Female-founded health tech company SheMed has reached unicorn status after a $50 million (£37.3m) raise taking its valuation to $1bn (£750m).
A study by the MHRA will use AI and NHS data to predict side effects from drug combinations before they ...
A study by the MHRA will use AI and NHS data to predict side effects from drug combinations before they reach patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback